Riverview Trust Company’s iShares US Medical Devices ETF IHI Stock Holding History

Riverview Trust Company’s Portfolio IHI Stock Details IHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-78	Closed	-$3K	–	330
2019 Q1	$3K	Buy	+78	New	+$2.83K	﹤0.01%	328

Other funds holding IHI

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Bank of Nova Scotia Toronto, Ontario, Canada $66.2B AUM 46.3% 1-Year Est. Return

Riverview Trust Company's IHI Position: Q2 2019 in Review

Riverview Trust Company sold out of iShares US Medical Devices ETF (IHI) in Q2 2019, closing a stake of 78 shares — an estimated $3K sold.

Riverview Trust Company first reported a position in IHI in Q1 2019 and held it in 1 quarter. The position peaked at $3K in Q1 2019. 296 funds tracked by Wall St. Rank hold IHI as of Q2 2019.

Riverview Trust Company reported no remaining iShares US Medical Devices ETF position as of Q2 2019 after selling out during the quarter.
Riverview Trust Company sold 78 iShares US Medical Devices ETF shares in Q2 2019, an estimated $3K.
Riverview Trust Company first reported a position in iShares US Medical Devices ETF in Q1 2019 and held it in 1 quarter.
Riverview Trust Company's iShares US Medical Devices ETF position peaked at $3K in Q1 2019.
296 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2019.

Based on Riverview Trust Company's 13F filing for Q2 2019, filed 12 Jul 2019.